tiprankstipranks
Trending News
More News >
Arcellx Inc (ACLX)
NASDAQ:ACLX
US Market

Compare Arcellx Inc (ACLX) vs. Competitors

Compare
318 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arcellx Inc
$114.60
$6.70B
-16.04
65.30%
0 Buy
15 Hold
0 Sell
Hold
Protagonist Therapeutics
$98.54
$6.29B
-42.66
87.16%
10 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$17.57
$2.25B
141.40
-27.22%
11 Buy
5 Hold
0 Sell
Moderate Buy
Immunovant
$24.38
$4.96B
-10.43
24.13%
8 Buy
2 Hold
0 Sell
Strong Buy
Beam Therapeutics
$24.63
$2.56B
-34.27
8.03%
12 Buy
2 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$16.27
$1.21B
-3.74
-57.95%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACLX
Arcellx Inc
114.60
42.12
58.11%
PTGX
Protagonist Therapeutics
98.54
46.01
87.59%
APLS
Apellis Pharmaceuticals
17.57
-6.69
-27.58%
IMVT
Immunovant
24.38
4.94
25.41%
BEAM
Beam Therapeutics
25.17
1.16
4.83%
MLTX
MoonLake Immunotherapeutics
16.87
-23.71
-58.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts